SCHEMBL4846166

SCHEMBL4846166

Cc1ccccc1-c1ccc(OCCN(C)C)c(C(=O)/C=C/c2ccccc2CN2CCN(C)CC2)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A9 P48067 3/20 0.44
HDAC3 O15379 4/20 0.41
HDAC4 P56524 4/20 0.41
HDAC1 Q13547 4/20 0.41
HDAC7 Q8WUI4 4/20 0.41
HDAC2 Q92769 4/20 0.41
HDAC10 Q969S8 4/20 0.41
HDAC11 Q96DB2 4/20 0.41
HDAC8 Q9BY41 4/20 0.41
HDAC6 Q9UBN7 4/20 0.41
HDAC9 Q9UKV0 4/20 0.41
HDAC5 Q9UQL6 4/20 0.41
KEAP1 Q14145 2/20 0.38
NFE2L2 Q16236 2/20 0.38
PDCD1 Q15116 2/20 0.38
CD274 Q9NZQ7 2/20 0.38
BACE1 P56817 1/20 0.38
HRH1 P35367 1/20 0.36
ALDH1A1 P00352 3/20 0.35
KDM4E B2RXH2 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4854720 1.00 SLC6A9 (0.44) SLC6A9HDAC3HDAC4HDAC1HDAC7
SCHEMBL4846414 0.94 SLC6A9 (0.42) SLC6A9KEAP1NFE2L2PDCD1CD274
SCHEMBL4852855 0.94 SLC6A9 (0.42) SLC6A9KEAP1NFE2L2PDCD1CD274
SCHEMBL4854510 0.91 KEAP1 (0.44) SLC6A9HDAC3HDAC4HDAC1HDAC7
SCHEMBL6142473 0.91 KEAP1 (0.44) SLC6A9HDAC3HDAC4HDAC1HDAC7
SCHEMBL4846175 0.91 HDAC3 (0.47) SLC6A9HDAC3HDAC4HDAC1HDAC7
SCHEMBL4847435 0.86 SLC6A9 (0.46) SLC6A9HRH1ALDH1A1KDM4ESMN1; SMN2
SCHEMBL4853568 0.86 SLC6A9 (0.46) SLC6A9HRH1ALDH1A1KDM4ESMN1; SMN2
SCHEMBL4854689 0.85 SLC6A9 (0.46) SLC6A9HRH1ALDH1A1KDM4ESMN1; SMN2
SCHEMBL4855044 0.85 SLC6A9 (0.46) SLC6A9HRH1ALDH1A1KDM4ESMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7423181-B2 in particular against bacterial and parasitic infections, fungi, and helminths; improved metabolic and physiochemical properties, bioavailability, solubility; 3-[4-(2-Dimethylamino-ethoxy)-2'-trifluoromethyl-biphenyl-3-yl]-1-(2-dimethylaminomethyl-phenyl)-propenone LICA PHARMACEUTICALS A/S (DK) 2008-09-09 US disclosed
US-20050227990-A1 Aminoalkoxy-functional chalcones LICA PHARMACEUTICALS A/S (DK) 2005-10-13 US disclosed